A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study.
Varlotto JM, Sun Z, Ky B, Upshaw J, Katz SI, Fitzgerald TJ, Wakelee H, Diehn M, Mankoff DA, Lovely C, Belani C, Oettel K, Masters G, Ramalingam S, Pennell NA.
Varlotto JM, et al.
Oncologist. 2021 Jun;26(6):523-532. doi: 10.1002/onco.13725. Epub 2021 Mar 11.
Oncologist. 2021.
PMID: 33594771
Free PMC article.
Review.